A new University of Michigan Medical School study discovered that the number of young adults living in the U.S. taking medicine to prevent HIV is at an all-time high, according to a release.
The researchers analyzed data from adults 18-25 in 2016-2023.
Key findings:
·PrEP use jumped from 26/100,000 to more than 208/100,000 in this age group.
·The higher end of the age group (22-25) filled more prescriptions than the lower end.
·People did not consistently refill their prescriptions.
·The number of young adults taking PrEP in the southern U.S. (a high-risk area) is growing.
It is noted that “the study also suggests that healthcare providers and public health agencies could do more to promote consistent use of these medications.”
